ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
5
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,569
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
Author(s):
P Morel
,
D Hober
,
I Dervite
Publication date:
2001-01-04
Journal:
The New England journal of medicine
Keywords:
Acute Disease
,
Aged
,
Antibodies, Monoclonal
,
adverse effects
,
therapeutic use
,
Antibodies, Monoclonal, Murine-Derived
,
Antineoplastic Agents
,
Hepatitis B
,
etiology
,
Hepatitis B Antibodies
,
blood
,
Hepatitis B Surface Antigens
,
immunology
,
Humans
,
Lymphoma, Follicular
,
complications
,
drug therapy
,
Male
,
Recurrence
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
11187122
DOI::
10.1056/NEJM200101043440120
ScienceOpen disciplines:
Chemistry
Keywords:
Acute Disease
,
Aged
,
Antibodies, Monoclonal
,
adverse effects
,
therapeutic use
,
Antibodies, Monoclonal, Murine-Derived
,
Antineoplastic Agents
,
Hepatitis B
,
etiology
,
Hepatitis B Antibodies
,
blood
,
Hepatitis B Surface Antigens
,
immunology
,
Humans
,
Lymphoma, Follicular
,
complications
,
drug therapy
,
Male
,
Recurrence
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Acute Disease
,
Aged
,
Antibodies, Monoclonal
,
adverse effects
,
therapeutic use
,
Antibodies, Monoclonal, Murine-Derived
,
Antineoplastic Agents
,
Hepatitis B
,
etiology
,
Hepatitis B Antibodies
,
blood
,
Hepatitis B Surface Antigens
,
immunology
,
Humans
,
Lymphoma, Follicular
,
complications
,
drug therapy
,
Male
,
Recurrence
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,569
Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection
Authors:
A. Adhikari
,
A. Eltahla
,
AR Lloyd
…
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
Authors:
Zhen-Yong Keck
,
Brian G Pierce
,
Patrick Lau
…
Treatment with AMG 420, an anti-B-cell maturation antigen (BCMA) bispecific T-cell engager (BiTE®) antibody construct, induces minimal residual disease (MRD) negative complete responses in relapsed and/or refractory (R/R) multiple myeloma (MM) patients: results of a first-in-human (FIH) phase I dose escalation study
Authors:
ST Max
,
Z Gerhard
,
A. Michel
See all similar
Cited by
33
Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients
Authors:
Junliang Fu
,
Weimin Nie
,
Zhengsheng Zou
…
Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
Authors:
Simone Lanini
,
Aoife C Molloy
,
Paul E M Fine
…
Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer
Authors:
Cristina Gutiérrez
,
Colleen McEvoy
,
Laveena Munshi
…
See all cited by